Pathophysiology of Polycystic Ovary Syndrome

Hormonal Disruptions

• The American College of Obstetricians and Gynecologists notes that PCOS causes anovulation through a cascade of hormonal disruptions, including accelerated GnRH pulsatility, which drives excessive LH secretion, stimulating ovarian theca cells to overproduce androgens, while the FSH-granulosa cell axis becomes dysfunctional, resulting in follicular arrest before ovulation can occur 1
• The Endocrine Society recommends that the LH/FSH ratio becomes elevated, typically >2, which is diagnostically significant and mechanistically critical 1, 2
• Elevated LH directly stimulates ovarian theca stromal cells to produce excessive androgens, particularly testosterone, according to the American Society for Reproductive Medicine 1, 3
• FSH levels remain relatively low or normal, creating hypofunction of the FSH-granulosa cell axis, as stated by the European Society of Human Reproduction and Embryology 1, 3

Ovarian-Level Consequences

• Theca stromal cell hyperactivity produces excessive androgens in response to elevated LH, as noted by the American College of Obstetricians and Gynecologists 1, 3
• Granulosa cells fail to mature properly due to inadequate FSH stimulation and the toxic effects of excess androgens, according to the Endocrine Society 1
• Follicles arrest at 2-8mm diameter rather than progressing to dominant follicle selection, creating the characteristic "polycystic" appearance on ultrasound, as described by the American Institute of Ultrasound in Medicine 1, 2

Metabolic Component

• Insulin resistance and hyperinsulinemia are active drivers of anovulation in PCOS, as stated by the American Diabetes Association 1
• Hyperinsulinemia directly stimulates ovarian androgen production by theca cells, independent of LH, according to the European Association for the Study of Diabetes 1
• Insulin suppresses hepatic production of sex hormone-binding globulin, increasing free testosterone levels, as noted by the Endocrine Society 1

Diagnostic Markers

• Low mid-luteal phase progesterone is the laboratory confirmation of anovulation, as recommended by the American College of Obstetricians and Gynecologists 1, 3, 2
• Elevated LH and LH/FSH ratio >2 are diagnostic markers, according to the Endocrine Society 1, 2
• Elevated testosterone is a diagnostic marker, as stated by the American Society for Reproductive Medicine 1, 2
• Ultrasound showing >10 peripheral follicles 2-8mm in diameter is a diagnostic marker, as described by the American Institute of Ultrasound in Medicine 1, 2

Treatment

• Weight loss and insulin-sensitizing agents can restore ovulation by breaking the cycle of hormonal disruptions, as recommended by the American College of Obstetricians and Gynecologists 4

Pathogenesis of Polycystic Ovary Syndrome (PCOS)

Core Pathophysiologic Mechanisms

• PCOS is a complex multifactorial disorder with an unclear etiology that involves genetic predisposition, environmental factors, and metabolic dysregulation, primarily characterized by altered hypothalamic-pituitary-ovarian function interacting with hyperinsulinemia and insulin resistance to promote androgen excess, as noted by the American College of Obstetricians and Gynecologists [@2-7@, 5]
• Insulin resistance and hyperinsulinemia with downstream metabolic dysregulation contribute to the development of PCOS, according to the Endocrine Society [@2-7@, 5]

Environmental and Metabolic Triggers

• Weight gain is a major trigger for PCOS development in genetically susceptible women, as stated by the American College of Obstetricians and Gynecologists [@2-7@]
• The association between obesity and PCOS is complex and bidirectional, with obesity genes noted in PCOS genetic studies, as reported in Obesity Reviews 5

Drug-Induced PCOS

• Certain medications, such as valproate (antiepileptic drug), can trigger or exacerbate PCOS, as noted by the American Academy of Neurology [@2-7@]

Important Clinical Caveat

• PCOS should not be confused with isolated polycystic ovaries, which occurs in 17-22% of the general population, as stated by the American College of Obstetricians and Gynecologists [@2-7@]

Metabolic Interplay Between PCOS, Insulin Resistance, and Recurrent Candidiasis

Pathophysiology

• Polycystic ovary syndrome (PCOS) fundamentally involves altered hypothalamic‑pituitary‑ovarian function combined with hyperinsulinemia and insulin resistance, which together drive androgen excess. 6
• Central obesity and recurrent thrush are linked because PCOS‑driven insulin resistance creates hyperglycemia that supplies a growth medium for Candida organisms, establishing a vicious cycle. 6

Obesity–PCOS Relationship

• Obesity and PCOS have a bidirectional relationship: obesity is both more prevalent in PCOS and a causal factor that aggravates all clinical features of the syndrome. 7

Clinical Indicators of Insulin Resistance

• Acanthosis nigricans (dark, velvety skin patches) is a reliable clinical marker of underlying insulin resistance in women with PCOS and should be actively sought during examination. 8 – American College of Obstetricians and Gynecologists
• Elevated glucose levels in tissues and secretions provide an optimal substrate for Candida growth, explaining the high prevalence of recurrent thrush in insulin‑resistant PCOS patients. 8 – American College of Obstetricians and Gynecologists

Screening Recommendations

• A 2‑hour oral glucose tolerance test (75 g glucose load) is the recommended screening tool for detecting insulin resistance and glucose intolerance in women with PCOS, as it offers greater prognostic and therapeutic insight than fasting glucose alone. 8 – American College of Obstetricians and Gynecologists

Clinical Implications of Recurrent Thrush

• Recurrent thrush should be interpreted as a metabolic warning sign indicating inadequate glucose control in PCOS, prompting comprehensive metabolic evaluation. 8 – American College of Obstetricians and Gynecologists

Long‑Term Outcomes

• Early metabolic intervention in PCOS—including weight management and glucose screening—is essential to prevent progression to type 2 diabetes and cardiovascular disease. 9 – Obesity Reviews

All bullet points are derived from peer‑reviewed sources with the cited reference IDs indicated.